Transport to a PCI centre improved long-term outcome more than thrombolytic therapy at the community hospital in acute MI: COMMENTARY

Wyer, Peter C.
September 2007
ACP Journal Club;Sept/Oct2007, Vol. 147 Issue 2, p34
Academic Journal
The article reports on an improved long-term outcome due to transport to a Percutaneous Coronary Intervention (PCI) center as compared to thrombolytic therapy at the community hospital in acute Myocardial Infarction (MI). It reports on replacing fibrinolytic therapy by PCI when both are accessible. It cites fewer problems like stroke in patient randomized to transport. It requires further work on the hypothesis related to long-term mortality benefit to patients in PCI group after symptom onset.


Related Articles

  • Left ventricular thrombus formation after acute myocardial infarction. Delewi, Ronak; Zijlstra, Felix; Piek, Jan J. // Heart;Dec2012, Vol. 98 Issue 23, p1742 

    The article offers information on the risks related to the formation of left ventricular (LV) thrombus after the occurrence of acute myocardial infarction (AFI). It informs that the risk of LV thrombus formation is highest during the first 3 months of following acute myocardial infarction. It...

  • Gender Is a Predictor of Increased Mortality in Myocardial Infarction. Rose, Verna L.; Haley, John H. // American Family Physician;6/1/1999, Vol. 59 Issue 11, p3157 

    Presents an abstract of a study presented at the 48th Annual Session of the American College of Cardiology which showed that gender is an important predictor of mortality associated with acute myocardial infarction in patients.

  • The TIMI risk score predicted mortality in patients with ST-elevation myocardial infarction. Ray, Joel // ACP Journal Club;Mar/Apr2002, Vol. 136 Issue 2, p76 

    Focuses on a study which examined the accuracy of Thrombolysis in Myocardial Infarction risk score for predicting in-hospital, or all-cause mortality in patients with ST-elevation myocardial infarction. Methodology of the study; Results; Comments on the study.

  • Treatment Delay Increases Mortality After Myocardial Infarction. Rose, Verna L.; Berger, Alan K. // American Family Physician;6/1/1999, Vol. 59 Issue 11, p3157 

    Presents a summary of a study presented at the 48th Annual Scientific Session of the American College of Cardiology which showed that patients with delayed thrombolytic therapy are at increased risk of mortality after myocardial infarction.

  • The effect of patients' time of arrival at the hospital on the rate of Thrombolytic therapy. Kazemi, Toba; Sharifzadeh, Gholam-Reza; Neikhonjy, Samaneh // ARYA Atherosclerosis;2013, Vol. 9 Issue 1, Special section p1 

    The article discusses a study which examined the effect of the arrival time of patients at the hospital on the rate of thrombolytic therapy. It was conducted on patients with ST segment elevation myocardial infarction or heart attack (STEMI) at Birjand Vali-e Asr Hospital in Iran. It relates the...

  • The Efficacy Of Thrombolytic Treatment On Patients Who Are Above 75 Years Of Age. Keles, Telat; Akar, Nihal; Gürsel, Koray; Canbay, Alper; Şahin, Deniz; Durmaz, Tahir; Diker, Erdem; Aydogdu, Sinan // Internet Journal of Cardiology;2006, Vol. 3 Issue 1, p2 

    Background: For acute myocardial infarction (AMI) patients above the age of 75, the efficacy of thrombolytic treatment could not be demonstrated clearly. Recently, depending on the data obtained from observational studies, it has been advocated that thrombolytic treatment might not be showing...

  • Review: an early invasive strategy has similar benefits in men and women with NSTEMI or unstable angina. O'Donoghue, M. // Evidence Based Medicine;Feb2009, Vol. 14 Issue 1, p11 

    The article presents a review on the benefits of an early invasive strategy in men and women with non-ST-segment elevation myocardial infarction (NSTEMI) or unstable angina. The review includes studies that compare the early invasive strategy with a conservative strategy in patients with NSTEMI...

  • Mortality benefit of thrombolytic, antiarrhythmic agents in MI therapy praised.  // Formulary;May96, Vol. 31 Issue 5, p411 

    Discusses the mortality benefit of thrombolytic and antiarrhythmic agents in myocardial infarction (MI) therapy. Study challenging angioplasty's superiority over thrombolysis for acute MI; Amiodarone's reduction of mortality due to arrhythmia in post-MI patients; Benefit of angiotensin...

  • Care in midair. Grim, Pamela // Discover;Nov98, Vol. 19 Issue 11, p44 

    Focuses on how a doctor and a nurse cared for a heart attack patient while he was being transferred to another hospital. Appearance of the patient; Vital signs; Monitoring equipment used; Reasons for the survival of the patient.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics